Johnson & Johnson developing stem cell cure for Type 1 diabetes
Johnson & Johnson and biotech company ViaCyte are exploring a possible cure for Type 1 diabetes with encouraging results, The Associated Press reports. The stem cell treatment involves turning embryotic stem cells into insulin-producing cells in a lab, and then putting them in a small capsule to implant under a patient's skin.
Patients with Type 1 diabetes cannot produce insulin. In a healthy person, insulin is made by the body in response to rising blood sugar levels after a meal. High levels of sugar in the bloodstream can lead to the damage of blood vessels, organs, and can even kill patients. Type 1 diabetes patients need to take frequent insulin injections as a result — something the insulin-implant produced by ViaCyte and Johnson & Johnson would render unnecessary.
Testing began on patients a year ago; they received a small dose of the insulin-producing cells in their implants and are to be closely monitored for two years. The companies reported that after 12 weeks, the patient's devices were working as expected with no side effects observed. Another several rounds of patient testing are expected before regulators will approve the device.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
About 29.1 million Americans have diabetes, which includes 1.25 million with Type 1, or insulin-dependent, diabetes. Type 2 diabetics — whose bodies make insulin but use it ineffectively — are on the rise, as are Type 1 diabetics. Current treatment includes a strict diet, exercise, and multiple daily insulin injections and finger-prick blood tests.
-
Antonia Romeo and Whitehall’s women problemThe Explainer Before her appointment as cabinet secretary, commentators said hostile briefings and vetting concerns were evidence of ‘sexist, misogynistic culture’ in No. 10
-
Local elections 2026: where are they and who is expected to win?The Explainer Labour is braced for heavy losses and U-turn on postponing some council elections hasn’t helped the party’s prospects
-
6 of the world’s most accessible destinationsThe Week Recommends Experience all of Berlin, Singapore and Sydney
-
Rubio boosts Orbán ahead of Hungary electionSpeed Read Far-right nationalist Prime Minister Viktor Orbán is facing a tough re-election fight after many years in power
-
Key Bangladesh election returns old guard to powerSpeed Read The Bangladesh Nationalist Party claimed a decisive victory
-
Epstein files topple law CEO, roil UK governmentSpeed Read Peter Mandelson, Britain’s former ambassador to the US, is caught up in the scandal
-
Iran and US prepare to meet after skirmishesSpeed Read The incident comes amid heightened tensions in the Middle East
-
EU and India clinch trade pact amid US tariff warSpeed Read The agreement will slash tariffs on most goods over the next decade
-
Israel retrieves final hostage’s body from GazaSpeed Read The 24-year-old police officer was killed during the initial Hamas attack
-
China’s Xi targets top general in growing purgeSpeed Read Zhang Youxia is being investigated over ‘grave violations’ of the law
-
Panama and Canada are negotiating over a crucial copper mineIn the Spotlight Panama is set to make a final decision on the mine this summer
